|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 2.106 SEK | -2.59% |
|
-15.76% | -56.17% |
| Market Cap | 832M 82.9M 73.7M 68.69M 62.61M 118M 7.98B 119M 323M 4.07B 311M 304M 13.19B | P/E 2026 * |
-4.43x | P/E 2027 * | -9.36x |
|---|---|---|---|---|---|
| Enterprise Value | 886M 88.27M 78.48M 73.15M 66.67M 126M 8.5B 127M 344M 4.34B 331M 324M 14.04B | EV / Sales 2026 * |
6.87x | EV / Sales 2027 * | 3.58x |
| Free-Float |
96.15% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ONCO | Delayed | |
CBOE
| ONCOs | Real-time | |
Deutsche Boerse AG
| OND | Delayed | |
London S.E.
| 0RN4 | Delayed | |
CBOE
| 0RN4 | Real-time | |
Börse Stuttgart
| OND | Delayed | |
Boerse Muenchen
| OND | Real-time |
Last Transcript: Oncopeptides AB
| 1 day | -2.59% | ||
| 1 week | -15.76% | ||
| Current month | -3.66% | ||
| 1 month | +11.13% | ||
| 3 months | +28.02% | ||
| 6 months | +50.43% | ||
| Current year | -56.17% |
| 1 week | 2.11 | 2.59 | |
| 1 month | 1.61 | 2.64 | |
| Current year | 1.26 | 4.91 | |
| 1 year | 1.26 | 6.55 | |
| 3 years | 1.1 | 9.4 | |
| 5 years | 1.1 | 50.84 | |
| 10 years | 1.1 | 215 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sofia Heigis
CEO | Chief Executive Officer | 46 | 2023-08-06 |
| Director of Finance/CFO | 52 | 2023-11-12 | |
Stefan Norin
CTO | Chief Tech/Sci/R&D Officer | 54 | 2023-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2011-12-31 | |
| Director/Board Member | 63 | 2017-01-31 | |
Per Wold-Olsen
CHM | Chairman | 78 | 2018-05-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/20/26 | Free | Chief Technology Officer | 3,000 | 0.0008% | ||
| 3/18/26 | Buy | 14,631 | 0.0038% | |||
| 3/17/26 | Free | Investor Relations Manager | 66 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.59% | -15.76% | -59.89% | -74.50% | 82.95M | ||
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | ||
| -3.11% | -3.53% | +21.92% | +74.60% | 57.39B | ||
| +0.89% | -0.63% | +4.28% | +34.51% | 47.64B | ||
| +0.36% | +0.81% | +352.17% | +689.61% | 44.29B | ||
| -0.96% | -4.50% | +26.36% | +33.18% | 42.5B | ||
| -0.20% | -0.77% | +3.74% | +100.60% | 40.71B | ||
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | ||
| -2.68% | +2.92% | +29.63% | +19.50% | 28.53B | ||
| +0.05% | -1.64% | -7.28% | -14.06% | 24.34B | ||
| Average | -0.46% | -2.11% | +42.96% | +100.80% | 39.06B | |
| Weighted average by Cap. | +0.12% | -0.84% | +58.74% | +129.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 129M 12.84M 11.42M 10.64M 9.7M 18.31M 1.24B 18.48M 50.02M 631M 48.21M 47.17M 2.04B | 252M 25.07M 22.29M 20.77M 18.93M 35.74M 2.41B 36.06M 97.63M 1.23B 94.11M 92.07M 3.99B |
| Net income | -167M -16.58M -14.74M -13.74M -12.53M -23.64M -1.6B -23.86M -64.59M -815M -62.26M -60.91M -2.64B | -62.47M -6.22M -5.53M -5.15M -4.7M -8.87M -599M -8.95M -24.23M -306M -23.35M -22.85M -990M |
| Net Debt | 54M 5.38M 4.78M 4.46M 4.06M 7.67M 518M 7.74M 20.94M 264M 20.19M 19.75M 856M | 68M 6.77M 6.02M 5.61M 5.11M 9.65M 652M 9.74M 26.37M 333M 25.42M 24.87M 1.08B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | SEK 2.106 | -2.59% | 2,262,233 |
| 26-10-01 | SEK 2.162 | -1.10% | 2,595,414 |
| 26-09-30 | SEK 2.186 | -3.02% | 3,205,625 |
| 26-09-29 | SEK 2.254 | -5.69% | 3,768,998 |
| 26-09-28 | SEK 2.390 | -4.40% | 4,254,335 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ONCO Stock
Select your edition
All financial news and data tailored to specific country editions

















